Major biotech stock tumbles 35 percent after major rare disease setback

thestreet.com/biotech/major-biotech-stock-tumbles-35-percent-after-major-rare-disease-setback

Biotech stories typically tread a very fine line between promise and pressure.
Sometimes a company that’s been a pioneer in rare diseases suddenly finds itself at a crossroads.
💵💰Don't miss the move: Subscribe to TheStreet's free daily newsletter💰💵
With years of headline-making science…

This story appeared on thestreet.com, 2025-07-18 20:54:13.
The Entire Business World on a Single Page. Free to Use →